Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,552,057
-$622,856 QoQ
Shares Held
642,946
-0.4% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#25
of 164 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $469,974,787 across 11 Drug Manufacturers - General names. GRFS ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
996,566 | $188,968,844 | |
| 2 | LLY |
ELI LILLY & Co
|
153,860 | $184,544,315 | |
| 3 | ABBV |
AbbVie Inc.
|
113,870 | $28,654,246 | |
| 4 | AMGN |
Amgen Inc
|
74,744 | $27,066,297 | |
| 5 | PFE |
Pfizer Inc
|
785,251 | $18,908,844 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,347 | $5,436,274 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
40,168 | $5,074,825 | |
| 8 | GRFS |
Grifols SA
This page
|
642,946 | $4,552,057 |
All Filings in GRFS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,552,057 | 642,946 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,174,913 | 645,251 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,033,096 | 645,251 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,426,699 | 645,251 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,689,450 | 629,364 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,168,059 | 586,225 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,053,527 | 544,829 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,591,972 | 517,114 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,759,230 | 437,279 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,921,023 | 437,279 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,494,805 | 388,824 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,199,054 | 350,006 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,039,370 | 331,809 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,192,398 | 297,476 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,222,138 | 261,428 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,236,533 | 200,736 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,014,812 | 169,597 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,487,804 | 212,997 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $2,349,248 | 209,194 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,610,138 | 110,208 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,954,251 | 112,637 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,003,617 | 115,883 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,138,505 | 115,971 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $283,846 | 16,360 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||